Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Patient Preference and Adherence|May 30, 2013
Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosisRobin K DoreCleveland Clinic Journal of Medicine|August 5, 2010
How to prevent glucocorticoid-induced osteoporosisRobin K DoreJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 10, 2008
Gout: what primary care physicians want to knowRobin K DoreRheumatic Diseases Clinics of North America|October 26, 2011
The RANKL pathway and denosumabRobin K DoreAdolescent Health, Medicine and Therapeutics|April 15, 2014
Clinical utility of etanercept in the treatment of arthritides in children and adolescentsRobin K DoreCurrent Osteoporosis Reports|November 17, 2011
Data from extension trials: denosumab and zoledronic acidRobin K DoreACR Open Rheumatology|November 18, 2021
The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United StatesRobin K Dore, Jenya N Antonova, Chakkarin Burudpakdee, et al.Current Medical Research and Opinion|August 7, 2009
Patient experience with a new teriparatide delivery deviceRobin K Dore, Robert G Feldman, Kathleen A Taylor, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 15, 2019
Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend TrialBenjamin Z Leder, Carol Zapalowski, Ming-Yi Hu, et al.Pageof 2